Celularity Inc. Adjustments to Additional Paid in Capital, Warrant Issued
Celularity Inc. (CELU) reported Adjustments to Additional Paid in Capital, Warrant Issued of $2.29 million for the 12-month period ending 2023-12-31, per its 10-K filed 2025-05-08.
Financial Statements › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued · last filed 2025-05-08
- Celularity Inc. adjustments to additional paid in capital, warrant issued for the quarter ending 2023-06-30 was $2.02M.
- Celularity Inc. adjustments to additional paid in capital, warrant issued for the quarter ending 2023-03-31 was $274.00K.
- Celularity Inc. adjustments to additional paid in capital, warrant issued for the quarter ending 2019-06-30 was $7.00M.
- Celularity Inc. adjustments to additional paid in capital, warrant issued for fiscal 2023 was $2.29M.
- Celularity Inc. adjustments to additional paid in capital, warrant issued for fiscal 2019 was $257.49M.
| Period end | Adjustments to Additional Paid in Capital, Warrant Issued 3 month | Adjustments to Additional Paid in Capital, Warrant Issued 6 month | Adjustments to Additional Paid in Capital, Warrant Issued 12 month | Adjustments to Additional Paid in Capital, Warrant Issued 12 month as first filed |
|---|---|---|---|---|
| 2023-12-31 | $2.29M 10-K · filed 2025-05-08 | $2.02M 10-K · filed 2024-07-30 | ||
| 2023-06-30 | $2.02M 10-Q · filed 2024-01-03 | $2.29M derived: sum of 2 quarters · filed 2024-12-06 | ||
| 2023-03-31 | $274.00K 10-Q · filed 2024-12-06 | |||
| 2019-12-31 | $257.49M 10-K/A · filed 2021-05-24 | $7.00M 10-K · filed 2020-03-24 | ||
| 2019-06-30 | $7.00M 10-Q · filed 2020-11-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |